Intravenous Clomipramine for Treatment-Resistant Obsessive-Compulsive Disorder

BACKGROUND: This open trial was conducted to evaluate the effectiveness of intravenous clomipramine (CMI) in refractory obsessive-compulsive disorder (OCD). METHODS: Thirty OCD poor responders to previous multiple trials of anti-obsessive medications were selected and admitted to the hospital. Sever...

Descripción completa

Detalles Bibliográficos
Autores principales: Karameh, Wael Karameh, Khani, Munir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772819/
https://www.ncbi.nlm.nih.gov/pubmed/26221004
http://dx.doi.org/10.1093/ijnp/pyv084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772819/
https://www.ncbi.nlm.nih.gov/pubmed/26221004
http://dx.doi.org/10.1093/ijnp/pyv084

Ejemplares similares